Abstinence effects and reactivity to nicotine during 11 days of smoking deprivation

Nicotine and Tobacco Research

Volumn 2, Issue 2, 2000, Pages 149-157

  Pomerleau, Ovide F ^a,b   Pomerleau, Cynthia S ^a   Marks, Judith L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLION STIMULATING AGENT; HYDROCORTISONE; NICOTINE;

ADULT; AFFECT; ANXIETY; ARTICLE; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ELECTRODERMAL RESPONSE; FEMALE; HEART RATE; HUMAN; MALE; METABOLISM; MIDDLE AGED; SMOKING; SMOKING CESSATION; THINKING; TIME;

ADULT; AFFECT; ANXIETY; BLOOD PRESSURE; FEMALE; GALVANIC SKIN RESPONSE; GANGLIONIC STIMULANTS; HEART RATE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; NICOTINE; SMOKING; SMOKING CESSATION; THINKING; TIME FACTORS;

EID: 0034186352     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/713688130     Document Type: Article

References (19)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington DC: American Psychiatric Association.
2. Fant RV, Schuh KJ, Stitzer ML. 1995. Response to smoking as a function of prior smoking amounts. Psychopharmacology 119:385-390.
3. Fischman MW, Foltin RW 1991. Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. British Journal of Addiction 86:1563-1570.
4. Gilbert DG, McClernon FJ, Rabinovich NE, Dibb WD, Plath LC, Hiyane S, Jensen RA, Meliska CJ, Estes SL, Gehlbach BA. 1999. EEG, physiology, and task-related mood fail to resolve across 31 days of smoking abstinence: relations to depressive traits, nicotine exposure, and dependence. Experimental and Clinical Psychopharmacology 7:427-443.
5. Hariharan M, VanNoord T, Greden JF. 1988. A high-performance liquid-chromatographic method for routine simultaneous determination of nicotine and cotinine in plasma. Clinical Chemistry 34:724-729.
6. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. 1991. The Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionniare. British Journal of Addiction 86:1119-1127.
7. Hughes JR. 1992. Tobacco withdrawal in self-quitters. Journal of Consulting and Clinical Psychology 60:689-697.
8. Hughes JR, Hatsukami DK, Pickens RW, Krahn D, Malin S, Luknic A. 1984. Effect of nicotine on the tobacco withdrawal syndrome. Psychopharmacology (Berl) 83:82-87.
9. Hughes JR, Higgins ST, Hatsukami D. 1990. Effects of abstinence from tobacco: a critical review. In: Kozlowski LT, Annis HM, Cappell HD, et al., eds. Research Advances in Alcohol and Drug Problems. New York: Plenum Publishing Corporation, pp. 317-398.
10. ™. A test strip method for analyzing nicotine and its metabolites in urine. Poster presented at the Annual Meeting of the American Thoracic Society and American Lung Association, San Francisco CA.
11. Perkins KA, Grobe JE, Mitchell SL, Goettler J, Caggiula A, Stiller RL, Scierka A. 1995. Acute tolerance to nicotine in smokers: lack of dissipation within 2 hours. Psychopharmacology 118:164-170.
12. Pilliteri JL, Kozlowski LT, Sweeney CT, Heatherton TF. 1997. Individual differences in the subjective effects of the first cigarette of the day: a self-report method for studying tolerance. Experimental and Clinical Psychopharmacology 5:83-90.
13. Pomerleau CS, Lutzke ML, Pomerleau OF, Hariharan M, Eswara AR. 1995. Preliminary evaluation of a semiquantitative urine test for nicotine and/or its metabolites. Poster presented at the Annual Meeting of the American Association for Clinical Chemistry, Anaheim, CA.
14. Pomerleau, OF. 1995. Individual differences in sensitivity to nicotine: implications for genetic research on nicotine dependence. Behavior Genetics 25:161-177.
15. Pomerleau OF, Pomerleau CS. 1990. Cortisol response to a psychological stressor and/or nicotine. Pharmacology, Biochemistry & Behavior 36:211-213.
16. Pomerleau OF, Flessland KA, Pomerleau CS, Hariharan M. 1992. Controlled dosing of nicotine via an Intranasal Nicotine Aerosol Delivery Device (INADD). Psychopharmacology 15:519-526.
17. Pomerleau OF, Pomerleau CS, Namenek RJ. 1998. Early experiences with nicotine among women smokers, ex-smokers, and never-smokers. Addiction 93:597-601.
18. Porchet HC, Benowitz NL, Sheiner LB. 1988. Pharmacodynamic model of tolerance: application to nicotine. The Journal of Pharmacology and Experimental Therapeutics 44:231-244.
19. Ward KD, Garvey AJ, Bliss RE. 1992. Evidence of transient heart rate change after smoking cessation. Psychopharmacology 106:337-340.